Cargando…
Resolution of epoetin‐induced pure red cell aplasia, successful re‐challenge with roxadustat
The application of erythropoietin (EPO) can bring about a rare but serious complication called anti‐EPO antibody‐mediated pure red cell aplasia (PRCA). Once the disease is diagnosed, EPO administration should be stopped immediately. However, after the removal of the anti‐EPO antibody, treating anaem...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754494/ https://www.ncbi.nlm.nih.gov/pubmed/32856389 http://dx.doi.org/10.1111/ijlh.13325 |